A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引：456
|
作者：
PETRELLI, N
HERRERA, L
RUSTUM, Y
BURKE, P
CREAVEN, P
STULC, J
EMRICH, LJ
MITTELMAN, A
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THERAPEUT,BUFFALO,NY 14263
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOMATH,BUFFALO,NY 14263
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 10期
关键词：
D O I：
10.1200/JCO.1987.5.10.1559
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1559 / 1565
页数：7
相关论文
共 50 条
  • [31] TRIAL OF 5-FLUOROURACIL AND CORYNEBACTERIUM-PARVUM IN ADVANCED COLORECTAL-CARCINOMA
    GOUGH, IR
    CLUNIE, GJA
    BOLTON, PM
    DURY, M
    BURNETT, W
    DISEASES OF THE COLON & RECTUM, 1979, 22 (04) : 223 - 227
  • [32] Double modulation of 5-fluorouracil by methotrexate and high-dose L-leucovorin in advanced colorectal cancer
    Romero, AO
    Perez, JE
    Cuevas, MA
    Lacava, JA
    Sabatini, CL
    Dominguez, ME
    Rodriguez, R
    Barbieri, MR
    Ortiz, EH
    Salvadori, MA
    Acuna, LAR
    Acuna, JMR
    Langhi, MJ
    Amato, S
    Machiavelli, MR
    Leone, BA
    Vallejo, CT
    Lorusso, V
    DeLena, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (01): : 94 - 98
  • [33] Randomized, phase II study comparing cisplatin and high-dose 5-fluorouracil/leucovorin with paclitaxel and high-dose 5-fluorouracil/leucovorin in patients with advanced gastric cancer and adenocarcinomas of the gastroesophageal junction
    Tesselaar, M. E.
    Luelmo, S.
    Polee, M.
    van Bochove, A.
    Ouwerkerk, J.
    Pruijt, H.
    Sleeboom, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer
    Kobayashi T.
    Koyama H.
    Oka T.
    Yasumura T.
    Kan N.
    Takatsuka Y.
    Noguchi M.
    Morimoto K.
    Suzuki T.
    Tobe T.
    Mori T.
    Breast Cancer, 1999, 6 (1) : 37 - 42
  • [35] Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil, and leucovorin versus oxaliplatin, 5-fluorouracil, and leucovorin versus 5-fluorouracil and leucovorin for patients with stage II or III rectal cancer receiving either preoperative radiation and 5-fluorouracil or postoperative radiation and 5-fluorouracil: ECOG E3201-An updated survival analysis.
    Nimeiri, Halla Sayed
    Feng, Yang
    Catalano, Paul J.
    Meropol, Neal J.
    Giantonio, Bruce J.
    Sigurdson, Elin R.
    Martenson, James A.
    Whitehead, Robert P.
    Sinicrope, Frank A.
    Mayer, Robert J.
    O'Dwyer, Peter J.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] A phase II trial of irinotecan, 5-fluorouracil and leucovorin in patients with previously untreated advanced colorectal cancer (CRC)
    Lee, N.
    Bae, S.
    Lee, S.
    Kim, D.
    Kim, K.
    Kim, H.
    Kim, C.
    Lee, K.
    Won, J.
    Hong, D.
    Park, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study
    Dufour, P
    Husseini, F
    Dreyfus, B
    Cure, H
    Martin, C
    Prevost, G
    Olivier, JP
    Dumas, F
    Duclos, B
    Olivares, R
    Leszler, A
    Bergerat, JP
    Audhuy, B
    Thill, L
    Oberling, F
    ANNALS OF ONCOLOGY, 1996, 7 (06) : 575 - 579
  • [38] Docetaxol 5-Fluorouracil, Cisplatin versus Epirubicin, 5-Fluorouracil, Cisplatin for advanced gastric carcinoma: Preliminary report
    Sadighi, Sanambar
    Mohagheghi, M. A.
    Raafat, J.
    ANNALS OF ONCOLOGY, 2004, 15 : 235 - 235
  • [39] Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: A GISCAD study
    Zaniboni, A
    Labianca, R
    Martignoni, G
    Barni, S
    Vinci, M
    Vaghi, M
    Pirovano, M
    Facendola, G
    Marini, G
    Luporini, G
    JOURNAL OF CHEMOTHERAPY, 1996, 8 (01) : 82 - 84
  • [40] Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer
    Baldini, E
    Gardin, G
    Giannessi, PG
    Evangelista, G
    Roncella, M
    Prochilo, T
    Collecchi, P
    Rosso, R
    Lionetto, R
    Bruzzi, P
    Mosca, F
    Conte, PF
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 227 - 232
12345